Literature DB >> 4813727

Sodium cyanate as a potential treatment for sickle-cell disease.

P N Gillette, C M Peterson, Y S Lu, A Cerami.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4813727     DOI: 10.1056/NEJM197403212901204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  A surprising journey in translational medicine.

Authors:  Anthony Cerami
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

2.  Formation of covalent adducts between cortisol and 16 alpha-hydroxyestrone and protein: possible role in the pathogenesis of cortisol toxicity and systemic lupus erythematosus.

Authors:  R Bucala; J Fishman; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

3.  Alternative pathway activation in sickle cell disease and beta-thalassemia major.

Authors:  A C deCiutiis; C M Peterson; M J Polley; L J Metakis
Journal:  J Natl Med Assoc       Date:  1978-07       Impact factor: 1.798

4.  Dimethyl adipimidate: a new antisickling agent.

Authors:  B H Lubin; V Pena; W C Mentzer; E Bymun; T B Bradley; L Packer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

Review 5.  Influence of High Hemoglobin-Oxygen Affinity on Humans During Hypoxia.

Authors:  Kevin L Webb; Paolo B Dominelli; Sarah E Baker; Stephen A Klassen; Michael J Joyner; Jonathon W Senefeld; Chad C Wiggins
Journal:  Front Physiol       Date:  2022-01-14       Impact factor: 4.755

Review 6.  Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Authors:  Sahir Kalim; S Ananth Karumanchi; Ravi I Thadhani; Anders H Berg
Journal:  Am J Kidney Dis       Date:  2014-07-16       Impact factor: 8.860

7.  Biological effects of short-term, high-concentration exposure to methyl isocyanate. I. Study objectives and inhalation exposure design.

Authors:  D E Dodd; F R Frank; E H Fowler; C M Troup; R M Milton
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.